86: The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS

Autor:	T. Newsom-Davis, R. Shah, Jason F. Lester, Denis Talbot, T. Talbot, M. Summerhayes, Jay Naik, Adam Dangoor, R. Cipelli, A. Patel
Rok vydání:	2017
Předmět:	Pulmonary and Respiratory Medicine Oncology Cancer Research medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) medicine.disease Sepsis Docetaxel Internal medicine medicine In patient business medicine.drug
Zdroj:	Lung Cancer. 103:S40-S41
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(17)30136-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::783a9c3cc685247ad1a558d3e35353bf https://doi.org/10.1016/s0169-5002(17)30136-8 Zobrazit plný text záznamu Full Text from ScienceDirect